The novel therapy of this peptide represents a major breakthrough in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide647867.bloggerbags.com/47771986/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment